---
title: "ADAPTATE BIOTHERAPEUTICS LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/7b61d8c3-769e-53c1-bf89-eab6f0cb539a
json: https://whiteintel.dev/api/public/dossier/7b61d8c3-769e-53c1-bf89-eab6f0cb539a
identifier: oo:GB-COH-12166787
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ADAPTATE BIOTHERAPEUTICS LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-12166787`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/7b61d8c3-769e-53c1-bf89-eab6f0cb539a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/7b61d8c3-769e-53c1-bf89-eab6f0cb539a  

## Ownership & control

### Owners / controllers

- **GAMMADELTA THERAPEUTICS LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/8644902a-8f92-5ab2-bf84-2826b5b10559
- **ABINGWORTH LLP** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/ca814fc6-d07e-51a9-aad7-7699e940f6fd
- **Takeda Pharmaceutical Company Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d629a8c3-067e-4c5c-8e55-556a03a31e30

### UBO chain (walk to the ultimate owner)

A **33-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `12166787`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2019-08-21
- **Registered office:** 1 Kingdom Street, London, W2 6BD, England
- **SIC:** 72110

### Officers

- DRISCOLL, Bryan — secretary · appointed 2022-04-26
- MEMIS, Seyda Atadan — director · Turkish · appointed 2022-08-01
- ROFFE, Emma Jane, Dr — director · British · appointed 2022-04-26
- GIBBONS, Mark — director · South African · appointed 2022-04-26 · resigned 2022-11-08
- GOODFELLOW, Peter Neville, Dr — director · British · appointed 2019-10-11 · resigned 2022-04-26
- HAINES, Timothy John — director · British · appointed 2019-10-11 · resigned 2022-04-26
- KEMP, Daniel Matthew — director · British · appointed 2019-10-11 · resigned 2021-04-06
- MOUNT, Natalie Marianne, Dr — director · British · appointed 2019-08-21 · resigned 2022-04-26
- NEAL, Jonathan Clark — director · British · appointed 2022-04-26 · resigned 2023-01-18
- SHIELDS, John Gerard, Dr — director · British · appointed 2019-10-14 · resigned 2022-04-26
- STONE, Victor, Dr — director · American · appointed 2021-09-01 · resigned 2022-04-26
- VINCENT, Loic — director · French · appointed 2019-10-11 · resigned 2021-08-20
- WARD, Christine Kim — director · American · appointed 2021-04-06 · resigned 2022-04-26

### Beneficial owners (Persons with Significant Control)

- [Gammadelta Therapeutics Ltd](https://whiteintel.dev/entity/8644902a-8f92-5ab2-bf84-2826b5b10559) — 75–100% shares · corporate PSC · United Kingdom — since 2022-08-01
- Takeda Pharmaceutical Company Limited — 75–100% shares · corporate PSC · Japan — ceased 2022-08-01
- [Abingworth Llp](https://whiteintel.dev/entity/ca814fc6-d07e-51a9-aad7-7699e940f6fd) — 25–50% shares · corporate PSC · England — ceased 2022-04-26

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/12166787

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ADAPTATE BIOTHERAPEUTICS LTD**. Human view: https://whiteintel.dev/entity/7b61d8c3-769e-53c1-bf89-eab6f0cb539a · Structured JSON: https://whiteintel.dev/api/public/dossier/7b61d8c3-769e-53c1-bf89-eab6f0cb539a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._